Actualités Stria Lithium Inc - SRA | Actions TSX Venture Exchange

Stria Lithium Announces Reverse Takeover with Grafoid Inc. and Announces Changes to Executive Leadership Team and Board of Di...

OTTAWA, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Stria Lithium Inc. (“Stria” or the “Company”) (TSX-V: SRA...

Stria Lithium Inc. Appoints Harry Martyniuk to Board of Directors

OTTAWA, Ontario, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Stria Lithium Inc. (“Stria” or the "Company") (TSX-V:...

Stria Lithium Inc. Engages NextCap Investor Relations to Provide Investor Relations Services and Increase Visibility in U.S. ...

OTTAWA, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Stria Lithium Inc. (“Stria” or the "Company") (TSX-V: SRA), a...

BTV-Business Television Features Sierra Geothermal, Starcore and Scorpio Mining Plus Analyst Mickey Fulp & CanGEA's Alison Thomp

VANCOUVER, British Columbia, April 15, 2010 (GLOBE NEWSWIRE) -- On Apr 17 and Apr 18, 2010 - on National TV, BTV-Business Television...

Merck Serono Named as a Top Employer by Science Magazine

GENEVA, Switzerland, October 10 /PRNewswire-FirstCall/ -- - Ranked Number 7 out of top 20 Employers Across Life Sciences Industry Merck Serono...

Squeeze Out of Merck Serono Shares Successfully Completed

Delisting of Merck Serono Shares Expected on July 18, 2007 GENEVA, Switzerland, July 6 /PRNewswire-FirstCall/ -- The Civil Court of Basel has...

Merck Initiates Squeeze Out Procedure for Shares of Merck Serono S.A.

Delisting Planned in Switzerland and in the U.S. GENEVA, Switzerland, March 21 /PRNewswire-FirstCall/ -- The Civil Court of Basle-City announced...

Merck Serono Confirms Previously Announced 2006 Figures

GENEVA, Switzerland, March 21 /PRNewswire-FirstCall/ -- Merck Serono S.A. (virt-x: SEO and NYSE: SRA) announced today that the preliminary...

Merck KGaA Announces Serono Preliminary Figures for 2006

GENEVA, Switzerland, March 1 /PRNewswire-FirstCall/ -- Merck KGaA today announced preliminary fourth quarter and full year results for the...

Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device

GENEVA, Switzerland, January 30 /PRNewswire-FirstCall/ -- - easypod(R) Was Designed to Improve Ease of Usage, Reliability and Convenience Merck...

Merck Serono Has Initiated the ONWARD Study to Evaluate Oral Cladribine as Add-on Treatment for Multiple Sclerosis

ONWARD Phase II Trial Will Assess Therapeutic Benefit of Oral Cladribine Added-on to New Formulation of Rebif(R) in Multiple Sclerosis Patients...

Merck Serono Announces Positive Results From Phase III Diet Study of Phenoptin for Phenylketonuria

Phenoptin Significantly Increases Phenylalanine Tolerance in BH4-Responsive Patients; All Pre-Specified Endpoints Met GENEVA, Switzerland...

Merck Serono Completes Patient Enrollment in CLARITY Phase III Pivotal Clinical Trial of Oral Cladribine

Oral Cladribine on Track to Become First Oral Disease Modifying Treatment for Multiple Sclerosis GENEVA, Switzerland, January 16...

Merck Serono is Launched

Top Management Appointed GENEVA, Switzerland, January 8 /PRNewswire-FirstCall/ -- Following the successful closing of the Share Purchase...

ZymoGenetics and Serono Begin Phase 2 Clinical Trial With Atacicept in Rheumatoid Arthritis

SEATTLE and GENEVA, Dec. 20 /PRNewswire-FirstCall/ -- ZymoGenetics, Inc. (NASDAQ:ZGEN) and Serono (NYSE: SRA; virt-x: SEO) today announced the...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Stria Lithium Inc (SRA)

Outils de qualité professionnelle, pour des investisseurs individuels.

SRA Actualités

Stria Lithium Announces Reverse Takeover with Grafoid Inc. and Announces Changes to Executive Leadership Team and Board of Di...

Stria Lithium Inc. Appoints Harry Martyniuk to Board of Directors

Stria Lithium Inc. Engages NextCap Investor Relations to Provide Investor Relations Services and Increase Visibility in U.S. ...

BTV-Business Television Features Sierra Geothermal, Starcore and Scorpio Mining Plus Analyst Mickey Fulp & CanGEA's Alison Thomp

Merck Serono Named as a Top Employer by Science Magazine

Squeeze Out of Merck Serono Shares Successfully Completed

Merck Initiates Squeeze Out Procedure for Shares of Merck Serono S.A.

Merck Serono Confirms Previously Announced 2006 Figures

Merck KGaA Announces Serono Preliminary Figures for 2006

Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device

Merck Serono Has Initiated the ONWARD Study to Evaluate Oral Cladribine as Add-on Treatment for Multiple Sclerosis

Merck Serono Announces Positive Results From Phase III Diet Study of Phenoptin for Phenylketonuria

Merck Serono Completes Patient Enrollment in CLARITY Phase III Pivotal Clinical Trial of Oral Cladribine

Merck Serono is Launched

ZymoGenetics and Serono Begin Phase 2 Clinical Trial With Atacicept in Rheumatoid Arthritis

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Stria Lithium Inc (SRA) Actualités

Stria Lithium Inc (SRA)

Outils de qualité professionnelle, pour des investisseurs individuels.

SRA Actualités

Stria Lithium Announces Reverse Takeover with Grafoid Inc. and Announces Changes to Executive Leadership Team and Board of Di...

Stria Lithium Inc. Appoints Harry Martyniuk to Board of Directors

Stria Lithium Inc. Engages NextCap Investor Relations to Provide Investor Relations Services and Increase Visibility in U.S. ...

BTV-Business Television Features Sierra Geothermal, Starcore and Scorpio Mining Plus Analyst Mickey Fulp & CanGEA's Alison Thomp

Merck Serono Named as a Top Employer by Science Magazine

Squeeze Out of Merck Serono Shares Successfully Completed

Merck Initiates Squeeze Out Procedure for Shares of Merck Serono S.A.

Merck Serono Confirms Previously Announced 2006 Figures

Merck KGaA Announces Serono Preliminary Figures for 2006

Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device

Merck Serono Has Initiated the ONWARD Study to Evaluate Oral Cladribine as Add-on Treatment for Multiple Sclerosis

Merck Serono Announces Positive Results From Phase III Diet Study of Phenoptin for Phenylketonuria

Merck Serono Completes Patient Enrollment in CLARITY Phase III Pivotal Clinical Trial of Oral Cladribine

Merck Serono is Launched

ZymoGenetics and Serono Begin Phase 2 Clinical Trial With Atacicept in Rheumatoid Arthritis

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités